How does Pyridium (phenazopyridine) affect urine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Pyridium (Phenazopyridine) Affects Urine

Pyridium (phenazopyridine) causes a distinct reddish-orange discoloration of urine and is rapidly excreted by the kidneys with up to 66% of an oral dose being excreted unchanged in the urine. 1

Primary Effects on Urine

Phenazopyridine has several notable effects on urine:

  • Color change: Creates a characteristic reddish-orange discoloration of urine
  • Rapid excretion: Up to 66% of the drug is excreted unchanged in urine 1
  • Topical analgesic effect: Exerts a local analgesic effect on the mucosa of the urinary tract, which helps relieve pain, burning, urgency, and frequency 1

Clinical Considerations

Laboratory Interference

  • Urinalysis interference: As an azo dye, phenazopyridine can interfere with urinalysis based on spectrometry or color reactions 1
  • False results: May cause inaccurate readings in diagnostic tests that rely on urine color changes
  • Contact lens staining: Can stain contact lenses when worn during treatment 1

Potential Adverse Effects

When using phenazopyridine, be aware of these potential complications:

  • Skin/sclera discoloration: A yellowish tinge of the skin or sclera may indicate drug accumulation due to impaired renal excretion, signaling the need to discontinue therapy 1
  • Renal toxicity: In overdose cases, can cause acute tubular necrosis and acute renal failure 2
  • Methemoglobinemia: Can occur even with relatively small doses, particularly in children 3, 4

Special Populations

Patients with Renal Impairment

  • Increased risk: Patients with decreased renal function may experience drug accumulation
  • Age consideration: The decline in renal function associated with advanced age should be kept in mind when prescribing 1

Pediatric Patients

  • Higher sensitivity: Children may develop methemoglobinemia with even small doses (as few as three tablets) 3
  • Observation period: Consider a 4-6 hour observation period or obtaining methemoglobin levels in children who ingest even small amounts 3

Patient Education Points

When prescribing phenazopyridine, inform patients about:

  • The normal reddish-orange discoloration of urine
  • Potential staining of clothing and fabrics
  • The temporary nature of these effects
  • The importance of completing the prescribed course despite the urine discoloration
  • When to seek medical attention (yellowing of skin/eyes, unusual fatigue, shortness of breath)

Duration of Treatment

Phenazopyridine should be used for short-term symptomatic relief only. Prolonged use increases the risk of adverse effects and may mask symptoms of underlying conditions requiring different treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.